UK stops providing AstaZeneca vaccine to people under 30 after EMA says vaccine has rare blood clot side effect.
The AstaZeneca coronavirus vaccine was found to cause rare blood clots, the European Medicines Agency ruled Wednesday.
EMA Executive Director Emer Cooke stated that this finding does not mean that the vaccine should not be used, as the side effect is extremely rare: "I want to start by stating that our safety committee the pharmacovigilance risk assessment committee of the European Medicines Agency has confirmed that the benefits of the AstraZeneca vaccine in preventing COVID19 overall outweigh the risks of side effects.”
Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more
Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens
“The PRAC, after a very in depth analysis, has concluded that the reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine," Cooke said.
“Based on the current available evidence, specific risk factors such as age, gender, or previous medical history of clotting disorders have not been able to be confirmed as the rare events are seen in all ages, and in men and women," she added.
In response to the announcement, British authorities have decided to limit administration of the AstaZeneca vaccine to people over the age of 30 and to provide an alternative vaccine to younger people. Read more at Arutz-7